Pelekanou, V., Villarroel-Espindola, F., Schalper, K. A., Pusztai, L., & Rimm, D. L. (2018). CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Breast Cancer Res.
Styl ChicagoPelekanou, Vasiliki, Franz Villarroel-Espindola, Kurt A. Schalper, Lajos Pusztai, a David L. Rimm. "CD68, CD163, and Matrix Metalloproteinase 9 (MMP-9) Co-localization in Breast Tumor Microenvironment Predicts Survival Differently in ER-positive and -negative Cancers." Breast Cancer Res 2018.
Citace podle MLAPelekanou, Vasiliki, et al. "CD68, CD163, and Matrix Metalloproteinase 9 (MMP-9) Co-localization in Breast Tumor Microenvironment Predicts Survival Differently in ER-positive and -negative Cancers." Breast Cancer Res 2018.